Skip Navigation



European Journal of Heart Failure Advance Access published online on November 25, 2009
European Journal of Heart Failure, doi:10.1093/eurjhf/hfp166
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
12/1/94    most recent
hfp166v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Haruki, S.
Right arrow Articles by Hagiwara, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haruki, S.
Right arrow Articles by Hagiwara, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report

Shintaro Haruki, Yuichiro Minami*, Katsuya Kajimoto, Bun Yashiro, Tsuyoshi Suzuki, Masatoshi Kawana and Nobuhisa Hagiwara

Department of Cardiology, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan

* Corresponding author. Tel: +81 3 3353 8111, Fax: +81 3 3356 0441, Email: yuichiro24{at}celery.ocn.ne.jp


  Abstract

It remains unclear whether the combination of dual-chamber (DDD) pacing and disopyramide can achieve prolonged left ventricular outflow tract (LVOT) gradient reduction and symptom relief in patients with obstructive hypertrophic cardiomyopathy (HCM). In an HCM patient with a severe LVOT gradient, the combination of DDD pacing and disopyramide achieved marked improvement of gradient in the catheter laboratory and also after medium-term follow-up. The patient's severe dyspnoea was alleviated during the follow-up period. This combination might enable physicians to treat and manage elderly symptomatic obstructive HCM patients with a severe LVOT gradient more effectively and less invasively.

Key Words: Hypertrophic cardiomyopathy • Dual chamber pacing • Disopyramide

Received April 9, 2009; Revised October 1, 2009; Accepted October 7, 2009


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.